Oak Associates’s CVS Health CVS Stock Holding History

Oak Associates’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-15,000	Closed	-$1.05M	–	134
2023 Q3	$1.05M	Sell	15,000 -3,200	-18%	-$227K	0.09%	96
2023 Q2	$1.26M	Buy	18,200 +3,200	+21%	+$228K	0.1%	97
2023 Q1	$1.11M	Buy	+15,000	New	+$1.26M	0.09%	103
2020 Q3	–	Sell	-22,826	Closed	-$1.48M	–	133
2020 Q2	$1.48M	Hold	22,826	–	–	0.1%	84
2020 Q1	$1.35M	Hold	22,826	–	–	0.11%	75
2019 Q4	$1.7M	Hold	22,826	–	–	0.1%	85
2019 Q3	$1.44M	Sell	22,826 -12,000	-34%	-$711K	0.09%	89
2019 Q2	$1.9M	Hold	34,826	–	–	0.12%	85
2019 Q1	$1.88M	Hold	34,826	–	–	0.11%	86
2018 Q4	$2.28M	Buy	34,826 +14,526	+72%	+$1.08M	0.16%	80
2018 Q3	$1.6M	Buy	20,300 +1,400	+7%	+$100K	0.1%	96
2018 Q2	$1.22M	Hold	18,900	–	–	0.08%	102
2018 Q1	$1.18M	Hold	18,900	–	–	0.08%	106
2017 Q4	$1.37M	Sell	18,900 -188,181	-91%	-$13.7M	0.1%	102
2017 Q3	$16.8M	Buy	207,081 +2,310	+1%	+$183K	1.24%	28
2017 Q2	$16.5M	Buy	204,771 +4,391	+2%	+$347K	1.24%	25
2017 Q1	$15.7M	Buy	+200,380	New	+$16M	1.26%	23

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Oak Associates's CVS Position: Q4 2023 in Review

Oak Associates sold out of CVS Health (CVS) in Q4 2023, closing a stake of 15,000 shares — an estimated $1.05M sold.

Oak Associates first reported a position in CVS in Q1 2017 and held it in 17 quarters. The position peaked at $16.8M in Q3 2017. 2,257 funds tracked by Wall St. Rank hold CVS as of Q4 2023.

Oak Associates reported no remaining CVS Health position as of Q4 2023 after selling out during the quarter.
Oak Associates sold 15,000 CVS Health shares in Q4 2023, an estimated $1.05M.
Oak Associates first reported a position in CVS Health in Q1 2017 and held it in 17 quarters.
Oak Associates's CVS Health position peaked at $16.8M in Q3 2017.
2,257 funds tracked by Wall St. Rank held CVS Health as of Q4 2023.

Based on Oak Associates's 13F filing for Q4 2023, filed 14 Feb 2024.